Innovate Biopharmaceuticals has signed an agreement with Amarex Clinical Research to provide data management and biostatistics for its planned Phase 3 celiac disease trial. Under the agreement, Amarex will provide Innovate with electronic data capture solutions and associated services for data management and biostatistics. June Almenoff, M.D., Ph.D., F.A.C.P, chief medical officer and chief operating officer of Innovate said, “With their strong expertise in biostatistics and data ma...